We sought to identify chronic pain patients' preferences for levels of improvement in pain-related morbidity (PRM) by measuring their willingness to pay (WTP) for reducing their pain intensity and pain-related disability. Methods: The study was a cross-sectional nonrandomized design. Participants were recruited from a tertiary multidisciplinary pain center in Canada. A computer-administered discrete-choice experiment was used to explore participants' WTP for various levels of improvement to PRM. Participants chose between two varying combination of treatments that differed in terms of their level of improvement in pain intensity, level of improvement in pain-related disability, and out-of-pocket monthly cost. Results: The WTP to completely minimize PRM was $1428 per month. Reduction in pain intensity was valued more highly than functional improvement. For every dollar, an individual was WTP to improve his/her disability to the lowest severity (mild), he/she was WTP approximately $2 to reduce pain intensity to moderate and $3 to reduce pain intensity to mild. The potential return on investment in terms of health improvement gained was $3318 per patient visit per year. Conclusion: The morbidity associated with chronic pain is worth approximately $1428 for every month in the chronic pain health state. From the patient's perspective, treatment and management strategies that focus on reducing pain intensity would have the greatest impact on improving health-related quality of life. Valuing health improvement in monetary terms allows for direct monetary comparisons between the costs of chronic pain interventions and their associated health returns.
Introduction
Chronic pain often occurs during the most productive years of life [1] . The estimated cost of lost productivity in the United States attributed to chronic pain is more than US$50 billion per year [2] with other estimates between US$85 and US$95 billion [3] . The full economic burden attributable to chronic pain is underestimated because little information has been collected about the intangible cost associated with the chronic pain health state (i.e., the economic burden of pain and suffering).
Pain-related morbidity (PRM) is composed of both pain intensity and pain-related disability [4] . Determining patient preferences in terms of willingness to pay (WTP) for levels of improvement to pain intensity and/or disability would provide insights that would lead to more effective pain management strategies because it would elucidate the relative value of improving pain intensity and/or disability for persons with chronic pain. Obtaining the WTP for improvements in PRM also quantifies the economic burden (i.e., intangible cost of pain and suffering) of chronic pain itself. Accordingly, the objective of the study was to identify chronic pain patients' preferences for levels of improvement in PRM by measuring their WTP for reducing pain intensity and/or improving disability in the context of a specialized pain center.
Methods

Population and Setting
A cross-sectional nonrandomized study design was conducted in the University of Alberta Hospital Multidisciplinary Pain Centre in 2007. Schedule of operation was from Monday to Thursday from 8:00 am to 4:30 pm. Patients attending the center were referred by their primary care physician. Patients attending the center undergo a triage and evaluation process by a pain specialist to identify inappropriate referrals (i.e., severity and complexity of their chronic pain condition can be managed through a primary care physician). Patients whose referral is deemed inappropriate are either placed on a waiting list or expedited if clinically appropriate. Nonpharmaceutical interventions are covered by the Alberta Health Care System. For pharmaceutical interventions, the majority of patients are required to provide a copayment through their insurance plans. Patients with lesser incomes who do not have insurance coverage for prescription medications are referred to social services to apply for financial assistance.
The study population was a random sample of individuals with chronic pain, who were 20 years and older who were not first-time attendees. Those who were involved in litigation or an insurance claim were excluded because of potential strategic behavior and bias. Ethical approval was obtained from the University of Alberta Health Research Ethics Board, and written informed consent was obtained from each study participant.
Disability Index [6] [7] [8] . In addition to having been validated for use in chronic pain populations [5] [6] [7] [8] , both these instruments are regularly used for assessing pain and disability in both research and clinical protocols at the multidisciplinary pain center, and respondents were therefore familiar with these instruments. Moreover, both measures were modified to facilitate comprehension based on information generated from pilot testing ( Fig. 1) . During pilot testing, it was determined that qualitative descriptive ranking used in combination with graphical illustrations improved respondent understanding of the various severities of pain intensity and disability. The use of visual aids in stated preference valuation techniques is also supported by relevant research [9] .
Based on these levels of pain intensity and disability, participants were classified into one of eight health states: total disability and excruciating pain (TDEP), total disability and severe pain (TDSP), total disability and moderate pain (TDMP), severe disability and excruciating pain (SDEP), severe disability and severe pain (SDSP), moderate disability and excruciating pain (MDEP), and moderate disability and severe pain (MDSP). No individuals presented with moderate pain intensity-moderate disability, moderate pain intensity-severe disability, nor were there any individuals with mild pain intensity or mild disability during pilot testing.
WTP Questionnaire
WTP was elicited using a set of discrete-choice experiments (DCE) [10] [11] [12] [13] . We sought to obtain an unbiased measure that represented only the burden of chronic pain by measuring WTP independent of treatment modality or other treatment factors (e.g., mode of administration, side effects, duration of improvement, etc.). Therefore, the DCE measured the WTP for treatments that improved pain intensity and/or disability, keeping all other treatment aspects identical.
Participants were presented with a series of choice scenarios where they could buy one of two hypothetical treatments that differed in three attributes: level of improvement in pain intensity, level of improvement in pain-related disability, and monthly out-of-pocket price. In each choice question, levels of improvement to pain intensity and disability were represented by graphical illustrations that replicated the categories used for measuring PRHS described above ( Fig. 2 ). After initial pilot testing, the out-of-pocket prices for each treatment ranged between $100 and $1000 per month. Better treatments were associated with higher price to ensure that participants would make trade-offs between improvements and price. This was also conducted to promote realism in the WTP questionnaire and the validity of choice responses because in real clinical settings, effective treatments are usually associated with higher costs.
Levels of improvements in the choice scenarios were dependent on the presenting individual's PRHS because WTP was based on treatments that improved upon one's PRHS. Therefore, a different WTP questionnaire was given to individuals with each presenting PRHS. WTP for improvements to no pain and no disability was not assessed because pilot testing revealed that including levels of "no pain" or "no disability" in the questionnaires compromised realism (e.g., a proportion of participants stated that such treatment outcomes were unrealistic). Therefore, there were seven separate questionnaires designed for individuals presenting with TDEP, TDSP, TDMP, SDEP, MDEP, SDSP, and MDSP. Questionnaires were designed to maximize orthogonality (i.e., minimize collinearity between attribute levels promoting statistical efficiency) and level balance (i.e., ensure attributes levels have an equal frequency of appearing throughout the questionnaire to minimize choice bias). An assessment of orthogonality found that correlations (Kendal-Tau) between treatment attributes were less than 0.40 for all the questionnaires, with the great majority of correlations being lower than 0.15. An assess-
Excruciating
Moderate
Severe Mild • Conduct family or home activities (example: chores, preparing meals, family outings). • Participate in recreation such as leisure, sports, or hobbies. • Socialize with friends (example: parties, movies, dining). • Work, keep employed, or volunteer. • Care for yourself in basic tasks (example: bathing, getting dressed, and eating).
PAIN INTENSITY VISUAL GUIDE
PAIN DISABILITY VISUAL METER
MILD DISABILITY MODERATE DISABILITY SEVERE DISABILITY TOTAL DISABILITY
Able with little difficulty to:
Barely able to:
Able but difficult to:
Completely unable to: Figure 1 Instruments used for assessing pain intensity and pain-related disability. Instruments were adapted from the Facial Pain Scale [5] and the Pain Disability Index [6] [7] [8] based on information generated from pilot testing.
ment of level balance found that attribute levels had a relatively equal frequency of appearing throughout each questionnaire.
Other Data
A demographic questionnaire was used to collect information on demographics, clinical history, and debriefing questions concerning the WTP questionnaire. Demographic information included marital status, smoking status, level of education, income, and other chronic conditions (e.g., diabetes). Debriefing questions included questions that targeted protest bias (i.e., Did respondents object to the questionnaire?), consequentiality (i.e., Was the questionnaire realistic and did individuals make trade-offs seriously?), ease of questionnaire, certainty in buying treatments, and the importance of treatment attributes. Information concerning clinical history included number of years with pain. Primary pain diagnosis, date of admittance, and date of birth was obtained from medical charts.
Procedure PRHS, WTP, and background questionnaires were administered in person by a single investigator. A clinic schedule of patients was obtained for each data collection day. Each patient in the list was assigned a number from which four individuals were randomly selected to participate in the study using a random number generator in Microsoft Excel. Individuals who preferred not to participate in the study were not replaced with another patient from the clinic schedule. PRHS was assessed using the questionnaire shown in Figure 1 . Participants were asked to indicate which of the illustrations best characterized their level of pain intensity, and second, the degree to which their pain affected their ability to conduct family activities, recreation, socialization, employment, and self-care.
Based on an individual's PRHS, a corresponding set of choice questions was loaded on a laptop computer screen. The participant was told that he/she would be presented with a series of treatments where he/she could buy either treatment A or B, or neither treatment. He/she was told that treatments A and B differed in the level of improvement of pain intensity, level of improvement of pain-related disability, and out-of-pocket cost per month after insurance. He/she was told that all other aspects of the treatment were identical (i.e., side effects, duration, and mode of administration). This was followed by a "cheap talk script" [14] indicating that although the choices were hypothetical, participants were to treat each choice seriously and to pretend that their choice was binding (i.e., that they would have to actually pay the price associated with the treatment chosen). Previous research has shown that cheap talk employed in choice experiments improves consequentiality and validity of WTP estimates [14] . Participants were given three practice questions before starting the WTP questionnaire. While completing the questionnaire, participants could refer to Figure 1 at any time.
After the WTP questionnaire, the background and debriefing questionnaire was given. The entire assessment including obtaining consent and administering questionnaires took approximately 20 minutes to complete. Data were collected over a 6-month period beginning in September 2006.
Analysis
Analysis of DCE data was conducted using two nested logistic regression models [13] . In the first model, we estimated WTP for improvements in PRHS excluding demographic or clinical variables (base model). This provided an overall mean estimate of WTP for each attribute and level of improvement. Attribute levels for pain intensity and pain-related disability were dummy coded using no change as the reference category. Cost of treatments was entered as a continuous variable. Alternative-specific constants for treatments A, B, and "neither option" were also included in the models. Adding constants for treatment A and B controlled the potential that there could be a preferential difference between treatment A and treatment B, irrespective of the treatment attributes (i.e., pain relief, disability improvement and cost) [13] .
The second model (base + demographics) was identical to the first model except that it included demographic and clinical variables. WTP may vary with attributes of treatment as well as characteristics of the patient [15] , and this model provided individual-specific WTP estimates by demographic and clinical factors. Because discrete-choice data are structured as panel data, incorporating demographic and clinical variables in the regression model required creating interaction terms between the dummy variables of the DCE attributes (i.e., levels of improvement in PRD and pain intensity) with demographic and clinical variables. Categorical demographic and clinical variables were effects coded [16, 17] . Effects coding is similar to dummy coding where L-1 variables are created. The difference between effects and dummy coding is that the reference level is coded 1 instead of 0. As a result, the effects of the reference level (within a categorical variable) is uncorrelated with the constant term but is instead internalized in the b estimates allowing one to estimate the effects of the reference level from the coefficients themselves independent of the constant term. Demographic variables included age (continuous), sex, marital status (single/separated/divorce, married/common-law), smoking status (current smoker, nonsmoker), level of education (did not complete postsecondary, completed postsecondary), and total annual household income. Income was coded into two dummy variables comparing total household incomes less than $30,000 with incomes $30,000 to $59,999 and incomes greater than $59,999. Clinical variables included months as a patient (continuous), number of years with pain (continuous), total number of comorbidities (continuous), and presence of depression (no, yes).
We hypothesized that preference for pain relief is affected by length of time as a patient, number of years living with chronic pain, and total number of comorbidities. Psychological distress and depression are known to be associated with chronic pain [18] [19] [20] . Therefore, clinical variables included months as a patient (continuous), number of years with chronic pain (continuous), total number of comorbidities (continuous), and presence of depression (yes, no).
Validity and Sensitivity Analysis
Three approaches were employed to increase the validity of our WTP findings. First, embedding effects (i.e., bias resulting from the sequence of questions or because treatment alternatives are presented in isolation of other available alternatives) and use of heuristics were tested by incorporating tests for consistency (i.e., Do participants answer the same question the same way?) and transitivity (i.e., Are their preferences for levels of improvements consistent throughout the questionnaire?) into the WTP questionnaire [10, 13] .
Second, content validity was formally tested by determining whether WTP was positively associated with higher income and self-reported preferences for DCE attributes. For example, WTP for pain reduction should be higher than the WTP for disability improvement for individuals who indicated that reducing pain is more important than improving disability. This was conducted in separate multinomial logistic regression models, which added self-reported preferences to the base + demographic model.
Third, we compared the WTP between individuals who indicated or did not indicate protest bias, lack of consequentiality, and purchase uncertainty in the base model. Protest bias was defined as individuals indicating they did not agree with paying for treatments. Lack of consequentiality was defined as indicating the following responses: improvements were good and individuals knew they did not have to pay for treatments; individuals did not believe level of improvement, or treatments were unrealistic. Uncertainty was defined as individuals indicating they were uncertain of whether they would purchase the treatments chosen.
Statistical Analysis
A linear additive model assumes that each attribute has an independent and linear effect on preferences [13] . The nested logistic regression analyses for both the base and base + demographic model were conducted separately for each version of the WTP questionnaire (i.e., for each presenting pain-related health state) but also for a data set that pooled the WTP data across individual health states. STATA 9.1 (StataCorp LP, College Station, TX) was used to analyze the DCE data. Model fit was assessed using pseudo R 2 . Model coefficients were considered statistically significant at P < 0.05. Power calculations for determining the sample size for DCEs are based on the number of choice questions contained in the WTP questionnaire [10] [11] [12] [13] . A power calculation was conducted to determine the appropriate sample size for each WTP questionnaire. WTP questionnaires for individuals presenting with TDEP, TDSP, TDMP, SDEP, MDEP, SDSP, and MDSP contained 34, 25, 16, 25, 16, 18 , and 11 choice questions that required 11, 15, 24, 15, 21, 24 , and 35 participants, respectively, at a = 0.05.
Calculating WTP
Each regression coefficient in the models represents the marginal effects of each attribute (amount of satisfaction gained from consuming one additional unit of that attribute). Therefore, dividing the marginal rates of substitution between the attributes and the price represents the trade-off between the satisfaction gained from "buying" that attribute and the cost of "buying" that attribute. Therefore, the WTP for any particular treatment attribute is calculated by dividing the regression coefficient of that attribute by the regression coefficient of price [10, 13] .
Results
Sample Characteristics
There were a total of 78 study participants (Table 1) . Participants presented with one of four health states: SDEP (n = 15), SDSP (n = 24), MDEP (n = 3), and MDSP (n = 36). The average age was approximately 48 years, with the majority being women, married/common-law, and nonsmokers, had completed postsecondary education, and had total annual household incomes $60,000 or greater. More than 50% of participants were being treated for back pain and migraine with 37% of participants having depression. The average length of time with chronic pain was 8 years, and participants had been attending the pain clinic for an average of 28 months. Table 2 shows the regression results from the base model. Note that data for individuals presenting with MDEP were pooled with individuals presenting with MDSP because there were only three individuals who presented with MDEP. The positive coefficient for improvements to pain-related disability and pain intensity indicates that individuals preferred improvements to their PRM. The negative coefficient on price indicated that individuals preferred treatments that cost less. The magnitude of the coefficients indicates that individuals preferred greater improvements in both pain-related disability and pain intensity. Furthermore, the magnitude of the coefficients for pain reduction were greater than those for disability improvement indicating that respondents preferred pain reduction over improvements in pain-related disability. Figure 3 shows the WTP results of the base model pooling across all study participants. Confidence intervals (CI) and statistical significance were calculated from standard errors generated from 1000 bootstrap replications. Pooling across health states indicate that overall, respondents were WTP $209 (95% CI: $31-$388) P < 0.021 per month for a reduction to moderate disability, $361 (95% CI: $200-$523) P < 0.001 per month for a reduction to mild disability, $225 (95% CI: -$28-$477) P < 0.08 per month for a reduction to severe pain, $681 (95% CI $478-$884) P < 0.001 per month for a reduction to moderate pain, and $1067 (95% CI: $836-$1298) P < 0.001 per month for a reduction to mild pain. The marginal WTP for a treatment that reduced both disability and pain intensity to a mild severity was $1428 per month ($361 + $1067). Table 3 shows the results from the base + demographic model for the pooled data (when pooling across all presenting PRHS). Note that WTP is only calculated for statistically significant coefficients. Older age was associated with lower WTP for a reduction to mild pain. Compared to women, men were WTP more for a reduction to mild pain but were WTP less for a reduction to moderate pain. Compared to individuals who were unmarried, married individuals were WTP more for a reduction to mild disability. Compared to nonsmokers, smokers were WTP more for a reduction to moderate disability and WTP less for a reduction to severe pain. Compared to individuals with less than $30,000 annual household income, individuals with $30,000 to $59,999 annual household income were WTP more for a reduction to mild disability, and individuals with greater than $59,999 annual household income were WTP more for a reduction to moderate pain and mild pain. Longer time as a patient was associated with lower WTP for a reduction to moderate pain. Compared to individuals without depression, individuals with depression were WTP less for a reduction to mild disability and mild pain.
WTP
Validity and Sensitivity Analysis
One hundred percent and 93.6% of participants passed the consistency and transitivity checks, respectively. In the base models, the pseudo R 2 values ranged from 0.2 to 0.4. In the base + exogenous models, the pseudo R 2 values ranged from 0.4 to 0.9. Marginal effects in the base and base + exogenous models were statistically significant, and the pain and disability attributes had the expected sign (+, -) and magnitude. Income was positively associated with higher WTP for improvements in both pain intensity and pain-related disability. WTP was positively associated with both, reported preferences for treatment attributes and treatments with greater improvements to pain intensity (in individuals presenting with greater pain intensity). In the pooled data, there were statistically significant differences in WTP between respondents who indicated purchase uncertainty. Respondents who indicated that they were certain of their choices had a lower WTP for improvements in PRM. Compared to respondents who were uncertain, the WTP for reducing pain intensity and painrelated disability to a mild severity was, respectively, $269 and $627 lower in respondents who were certain. 
Discussion
The societal impact of chronic pain is significant and should be of great concern to policymakers because of the rising prevalence and escalating burden on already stretched health-care resources.
To provide insight, which may reinforce the need for more effective pain management strategies, and to quantify the economic burden of the chronic pain health state, we measured the WTP for reducing pain intensity and/or improving pain-related disability for persons with chronic pain. Our results indicate that persons with chronic pain are WTP significant amounts to minimize their PRM. Furthermore, WTP does vary by background and clinical factors. The base model showed that overall (i.e., pooled results), persons with chronic pain are WTP $361 and $1067 per month to improve pain-related disability and reduce pain intensity to a mild severity, respectively. Nevertheless, WTP was lower in respondents who indicated that they were certain of their treatment choices. Thus, our sample population was WTP approximately $17,000 per year to minimize PRM, as far as our hypothetical choice model allowed. The average gross annual family income of our sample (calculated by using the midpoint in income categories as a point estimate) was $33,000, suggesting that our sample population was willing to allocate 52% of their gross family income to minimize their morbidity caused by chronic pain.
Policy Implications
In contrast with other approaches for valuing health (e.g., quality-adjusted life-years), monetizing health improvement allows for direct monetary comparisons between the amount of dollars invested in services that improve health and their associated health improvement. To illustrate, we can estimate the amount of health improvement, expressed in dollars that can be generated from the resources invested to operate the Multidisciplinary Pain Centre. Consider the following: In 2007, the Multidisciplinary Pain Centre had 2234 patient visits. Assuming that multidisciplinary treatment for chronic low back pain is 67% effective at returning individuals to work in 6 months [21] , which is equivalent to an improvement to a moderate severity in PRM, the amount of "health improvement" generated from these patients was worth approximately $8 million per year (1496 ¥ $890 ¥ 6). The average fee per physician visit is assumed to be $177.56 per visit (fee code 03.08F) [22] . Therefore, the total physician visit costs for the Multidisciplinary Pain Centre was approximately $400,000 per year. Annual operating cost of the Multidisciplinary Centre, including nursing, equipment, and supplies, was approximately $180,000. Therefore, the return on investment is approximately $7.4 million worth of health improvement per year or $3318 per patient visit per year (Note: this does inform whether resources could be applied more efficiently elsewhere).
Clinical Implications
From a clinical perspective, our results indicate that persons with chronic pain strongly prefer pain reduction over disability improvement (Fig. 3) . Regardless of presenting severity in disability, for every dollar an individual was WTP to improve their disability to the lowest severity (mild), he/she was WTP approximately $2 to reduce pain intensity to moderate and approximately $3 to reduce pain intensity to mild. This suggests that treatment and management strategies that target pain intensity over improvements in disability would have the greatest impact on improving health-related quality of life for persons with chronic pain. 
The Value of Pain Reduction
Our results, therefore, support a refocusing of clinicians efforts toward reducing pain intensity instead of focusing on the acceptance of pain and the pursuit of normal life activities [23] . This is a difficult notion for many clinicians who are faced with the challenge of trading the risks of what chronic patients prefer, which we found above all else is a reduction in pain intensity, with the real concerns about the risk, safety, and uncertainty of treatments currently available. Further research should elucidate the trade-off between risks and benefits from a patient perspective and hence provide insight for developing clinical guidelines around the use of effective, yet potentially harmful treatments.
Strengths and Limitations
There are several strengths to our analysis, which increase the validity of our findings. First, tests for consistency and transitivity confirm that the large majority of respondents were not using heuristics. Second, WTP was positively associated with higher income and with self-reported preferences for attributes of pain reduction, indicating that our results are consistent with underlying theory. Construct validity was further evidenced by the fact that model coefficients were statistically significant, had the expected sign (+, -), that WTP increased with greater improvement in pain intensity in individuals presenting with greater pain severity, and that the association between WTP and demographic/clinical variables were consistent with our a priori hypotheses and existing published research.
Our results, however, should also be evaluated in light of study limitations. First, WTP for improvements in PRM is influenced by factors such as efficacy, safety, time to relief, side effects, and duration of effect [24, 25] . It is important to reiterate that our objective was to provide a measure that represented the burden of the chronic pain health state itself and not to valuate any specific type of treatment characteristics or modes of administration. Nevertheless, we acknowledge that WTP is influenced by other factors that, when taken into account, would likely reduce our WTP estimates. For instance, in a study of pharmaceutical treatment for chronic migraineurs, Lenert [25] found that compared to an ideal treatment (e.g., immediate relief and no side effects), WTP was reduced by 43% for treatments, with a chance of rebound headache, being unable to go to work, delay in relief, and shorter duration of relief. Thus, our results reflect the valuation of the chronic pain health state, which can be considered an upper bound estimate of chronic pain patients' WTP for improvements in PRM.
Second, our results are limited in the applicability for informing societal prioritizations for two primary reasons. The WTP valuations are based on patient preferences for improvements in PRM and do not reflect societal preferences. Additionally, WTP is affected by ability to pay (i.e., income), and only 40% of our study population had family incomes greater than $50,000 per year that is likely not representative of the family income of the average taxpayer in Alberta, which was $78,400 in 2006 (Statistics Canada: http://www40.statcan.ca/l01/cst01/famil108 a.htm?sdi=family%20income). Although valuing the chronic pain health state requires valuations from individuals who have experienced chronic pain opposed to the general population, the WTP results do not inform the value that society in general places on improving PRM.
Third, the severity of chronic pain in our study population was not representative of the severity of chronic pain sufferers who can be satisfactorily managed by their primary care physician. Therefore, our results can only be generalized to persons with chronic pain whose severity necessitates care beyond those offered by primary care. Nevertheless, given the extant research and our interactions with other tertiary care multidisciplinary pain centers across the world, it is our impression that the population sampled in this study would be similar to that of other tertiary care multidisciplinary pain centers in most developed countries. This, however, remains to be resolved by future WTP research conducted in other chronic pain settings, including tertiary care and primary care populations.
Fourth, to minimize bias resulting from strategic behavior, we excluded individuals who were involved in litigation or an insurance claim. We also only included individuals who were 20 years or older who were not newly referred patients. Consequently, the study inclusion and exclusion criteria introduce the possibility for selection bias. Therefore, it must be emphasized that our results reflect the WTP of individuals who were 20 years and older, not newly admitted patients, and who were not involved in litigation or an insurance claim. Approximately 5% of the randomly selected participants were involved in litigation or an insurance claim and were excluded from the study population. Compensation for injury is an important issue and valuing the WTP for pain relief in individuals involved in litigation or insurance would provide insight into issues around compensation for pain and suffering.
Fifth, although various methods (e.g., in-person administration and cheap talk script) were employed to increase the validity of the choice responses (discussed in methods section), it is not certain whether the WTP estimates reflect what would have been observed in a real market. It is important to point out that real markets for treatments available for the level of severity in this patient population do not exist in a publicly funded health-care Willingness to pay for improvements to pain intensity and/or pain-related disability using pooled data. Note: WTP is calculated for coefficients that were statistically significant shown in Table 2 . Confidence intervals and P-values were calculated from standard errors generate from 1000 bootstrap replications.
system. The WTP for reducing pain intensity and pain-related disability to a mild severity was, respectively, $269 and $627 lower in respondents who were certain than in respondents who were uncertain of their choice responses.
Conclusion
In conclusion, four main points emerge from the study. First, the morbidity associated with severe chronic pain is worth approxi- Note that only statistically significant coefficients are included in the calculation of WTP.
The Value of Pain Reduction mately $1428 for every month in the chronic pain health state. Second, treatment and management strategies that focus on reducing pain intensity would have the greatest impact on improving health-related quality of life. Third, valuing health improvement in monetary terms provide an opportunity for making direct monetary comparisons between the resource investment in interventions targeting chronic pain and the health return on that investment. Finally, future research in pain valuation should focus on the trade-off between treatment risk and benefits from a patient perspective to provide guidance around the use of potentially harmful treatments with known effectiveness.
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